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ABSTRACT: In humans, the gene encoding a reverse
thymidylate synthase (rTS) is transcribed in the reverse
direction of the gene encoding thymidylate synthase (TS) that
is involved in DNA biosynthesis. Three isoforms are found: α,
β, and γ, with the transcript of the α-isoform overlapping with
that of TS. rTSβ has been of interest since the discovery of its
overexpression in methotrexate and 5-ﬂuorouracil resistant cell
lines. Despite more than 20 years of study, none of the rTS
isoforms have been biochemically or structurally characterized.
In this study, we identiﬁed rTSγ as an L-fuconate dehydratase
and determined its high-resolution crystal structure. Our data provide an explanation for the observed diﬀerence in enzymatic
activities between rTSβ and rTSγ, enabling more informed proposals for the possible function of rTSβ in chemotherapeutic
resistance.
■ INTRODUCTION
In establishing a quantitative PCR assay for human thymidylate
synthase (TS), a partially overlapping gene at the chromosome
location 18p11.32, designated reverse thymidylate synthase
(rTS), was found to be transcribed in the reverse direction
with marginal overlap between the 3′-untranslated region of
rTS and the last intron of TS.1 Since then, two other isoforms
have been identiﬁed from alternatively spliced mRNA, yielding
a total of three isoforms: rTSα (Uniprot ID G2MQH2), rTSβ
(G2MQH3), and rTSγ (Q7L5Y1).2,3 All three proteins share
the same 341 C-terminal amino acid sequence but diﬀer in their
N-terminal sequences and lengths. rTSα appends an additional
20 residues to the N-terminal of the shared sequence making it
a 361 residue polypeptide. rTSβ has a diﬀerent N-terminal
sequence of 75 residues making it a 416 residue polypeptide,
while rTSγ appends an additional 27 amino acids to the N-
terminus of rTSβ to form a 443 residue polypeptide
(Supporting Information Figure S1). The rTS genes have
been of clinical interest in the cancer research community for
over 20 years, yet their functions remain largely unknown. The
main interest lies in the correlation of cell lines resistant to the
common chemotherapeutics methotrexate and 5-ﬂuorouracil,
with rTSβ overexpression.2−7 Methotrexate is a competitive
inhibitor of dihydrofolate reductase (DHFR), and 5-ﬂuorour-
acil is an irreversible inhibitor of TS. Both DHFR and TS play
central roles in the synthesis of dTMP, a precursor for DNA
synthesis. In clinical studies, rTSβ was found to be expressed in
breast cancer tissue but not the surrounding tissues.8
Furthermore, a statistically signiﬁcant correlation was found
between the level of rTSβ expression and a decrease in the ﬁve
year survival rate of colon cancer patients.5 The 27 residue
longer N-terminus of rTSγ, compared to rTSβ, is proposed to
constitute a mitochondrial signaling sequence,9 suggesting that
rTSβ and rTSγ serve similar enzymatic functions. The function
of rTSα, the shortest of the three proteins, remains to be
postulated.
Based on sequence homology and inspection of key catalytic
residues, the three rTS isozymes are members of the mandelate
racemase (MR) subgroup of the enolase superfamily (ENS)
that is known to catalyze the racemization of mandelate as well
as dehydration of various acid sugars.10 All ENS members
catalyze the abstraction of a proton alpha to a carboxylate group
of the substrate to form a Mg2+ stabilized enediolate anion,
although the overall reaction is not conserved.11 Furthermore,
members of the ENS share common structural motifs that form
the catalytic machinery, including a capping domain for
substrate speciﬁcity and a (β/α)7β-barrel domain for acid/
base chemistry.12,13
In order to provide functional insights into the medically
relevant rTSβ and facilitate future studies, we isolated
recombinant human rTSβ and rTSγ isoforms, identiﬁed rTSγ
as an L-fuconate dehydratase using a medium throughput
enzymatic screen, and determined the crystal structure of rTSγ
at 1.74 Å resolution.
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■ MATERIALS AND METHODS
Cloning, Expression, and Puriﬁcation of Human rTSγ
(HsrTSγ). A DNA fragment containing residues 1−440 of
HsrTSγ (IMAGE clone: 3454185) was subcloned into the
pNIC28-Bsa4 vector (GenBank accession EF198106) incorpo-
rating an N-terminal TEV-cleavable His6-tag. The plasmid was
transformed into E. coli BL21(DE3)-R3-pRARE2 cells, grown
overnight at 18 °C in 12 L of TB medium after induction by 0.1
mM IPTG. Cells were harvested, lysed in buﬀer A (50 mM
HEPES, pH 7.4, containing 500 mM NaCl, 5% glycerol, 10 mM
imidazole, 0.5 mM TCEP, and an EDTA-free protease
inhibitor), and centrifuged to remove insoluble debris.
The initial stage of puriﬁcation involved passing the clariﬁed
cell extract through a 2.5 mL column of Ni-NTA resin pre-
equilibrated with buﬀer A. Bound protein was eluted with
buﬀer B (buﬀer A + 250 mM imidazole). The fractions
containing HsrTSγ were applied onto a HiLoad 16/60
Superdex 200 column pre-equilibrated with GF buﬀer (10
mM HEPES, pH 7.4, containing 500 mM NaCl, 5% glycerol,
and 0.5 mM TCEP). Fractions containing HsrTSγ were treated
with TEV protease overnight at 4 °C, and passed over Ni-
Sepharose resin pre-equilibrated with GF buﬀer. The tagless
protein was then diluted to 50 mM NaCl, and applied to a 1
mL Resource-S column pre-equilibrated with IEX buﬀer (50
mM Tris−HCl pH 8.5, containing 50 mM NaCl). Protein was
eluted with a linear gradient of 0−500 mM NaCl and
concentrated to 35 mg/mL for storage at −80 °C. Further
puriﬁcation details can be found at http://www.thesgc.org/
structures/4a35.
Crystallization, Data Collection, and Structure Deter-
mination. Crystals of HsrTSγ were grown by vapor diﬀusion at
20 °C. A sitting drop containing 100 nL protein (35 mg/mL)
and 50 nL well solution was equilibrated against well solution
containing 25% (v/v) PEG3350 and 0.1 M Bis-Tris, pH 5.5.
Crystals were mounted in the presence of 25% (v/v) ethylene
glycol and ﬂash-cooled in liquid nitrogen. Diﬀraction data for
the native HsrTSγ crystal were collected at the Diamond Light
Source beamline I03 and processed with the XDS and SCALA.
HsrTSγ crystallized in the hexagonal space group P6522 with
one polypeptide in the asymmetric unit. The structure was
solved by single-wavelength anomalous dispersion (SAD)
phasing.
Crystals were derivatized by incubation with reservoir
solution supplemented with 1 mM thiomersal for 60 min.
Diﬀraction data were collected at the Diamond Light Source
beamline I03, and processed and scaled with XDS14 and
Scala,15 respectively. SHELXD16 identiﬁed two heavy atom
sites, and after phase reﬁnement in SHARP17 and subsequent
density modiﬁcation with SOLOMON, 18 an electron density
map of excellent quality was obtained and substantial parts of
the model were automatically built with ARP/wARP.19 The
resulting model was reﬁned against the native data, where
manual model rebuilding was carried out with Coot,20 and
structure reﬁnement with BUSTER (Global Phasing Ltd.,
Cambridge, UK).
Cloning, Expression, and Puriﬁcation of Human rTSβ
(HsrTSβ). The gene encoding HsrTSβ was PCR ampliﬁed from
the HsrTSγ:pNIC28-Bsa4 plasmid using platinum Pfx polymer-
ase (Invitrogen). The PCR reaction (30 μL) contained 50 ng
template, 1 mM MgCl2, 1X Pfx Amp Buﬀer, 0.33 mM dNTP,
0.33 μM of each primer (forward primer 5′-TGGGTACCG-
AGAACCTGTACTTCCAACATATGCACACGGACCC-3′
and reverse primer 5′-CAGTGGTGGTGGTCGTGGTGC-
TCGAGT3′), and 1.25 units Pfx polymerase (Invitrogen
Platinum Pfx DNA Polymerase kit). Ampliﬁcations were
performed according to the manufacturer’s guidelines. The
ampliﬁcation product was digested by NdeI and EcoRI (New
England Biolabs) and ligated into NdeI/EcoRI digested
pET17b (Novagen). The rTSβ gene in pET17b was expressed
in Escherichia coli BL21 (DE3). Small-scale cultures were grown
at 37 °C for 18 h in 5 mL of LB containing 100 μg/mL
ampicillin and used to inoculate 1 L LB containing 100 μg/mL
ampicillin. The 1 L cultures were grown for an additional 18 h
at 37 °C without induction. The cells were harvested by
centrifugation at 5000 rpm for 10 min and resuspended in 70
mL of binding buﬀer (6 mM imidazole, 20 mM Tris−HCl, 5
mM MgCl2, and 500 mM NaCl, pH 7.9). The resuspended
cells were lysed by sonication and centrifuged at 17,000 rpm for
30 min. The supernatant was loaded onto a 300 mL DEAE-
Sepharose column (Amersham Biosciences) and eluted with a
NaCl gradient (0 - 1 M over 1.6 L) in 10 mM Tris−HCl, pH
7.9, containing 5 mM MgCl2. Fractions were analyzed using
SDS-PAGE. Fractions that contained rTSβ were combined and
dialyzed for 2 h at 4 °C against 4 L of 10 mM Tris−HCl, pH
7.9, containing 5 mM MgCl2. The dialyzed protein was then
loaded onto a 30 mL Q-Sepharose column (Amersham
Biosciences) and eluted with a NaCl gradient (0−1 M over
500 mL) in 10 mM Tris−HCl, pH 7.9, containing 5 mM
MgCl2. Fractions were analyzed using SDS-PAGE. Fractions
that contained HsrTSβ at high purity were combined and
dialyzed for 2 h at 4 °C against 4 L of 10 mM Tris−HCl, pH
7.9, containing 5 mM MgCl2. Ammonium sulfate was added to
a ﬁnal concentration of 1 M, and the protein was loaded onto a
30 mL phenylsepharose column (Amersham Biosciences). The
protein was eluted with a gradient of ammonium sulfate (1−0
M over 500 mL) in 10 mM Tris−HCl, pH 7.9, containing 5
mM MgCl2. Fractions were analyzed using SDS-PAGE.
Fractions with pure HsrTSβ were combined and dialyzed for
2 h at 4 °C against 4 L of 10 mM Tris−HCl pH 7.9, containing
5 mM MgCl2, 100 mM NaCl, and 10% glycerol. Finally, the
protein was concentrated to 7.6 mg/mL, ﬂash frozen using
liquid N2, and stored at −80 °C prior to use.
Screen for Dehydration. Reactions to test for dehydration
activity for HsrTSβ and HsrTSγ were performed in acrylic, UV
transparent 96-well plates (Corning Incorporated) using a
library of 72 acid sugars (Supporting Information Figure S2).
Reactions (60 μL total volume) contained 50 mM HEPES, pH
7.9, 10 mM MgCl2, 1 μM enzyme, and 1 mM acid sugar
substrate (blanks with no enzyme). The plates were incubated
at 30 °C for 16 h. After incubation, 240 μL of a semicarbazide
solution (1% semicarbazide w/v, 1% sodium acetate w/v) was
added to each well and the plate was incubated for 1 h at room
temperature. The absorbance at 250 nm was measured
(semicarbazone ε = 10,200 M−1 cm−1) using an Inﬁnite
M200 PRO microplate reader (Tecan Group Ltd.).
Kinetic Assays of HsrTSγ. Kinetic constants for the
dehydration of L-galactonate, D-arabinonate, L-arabarate, and
D-ribonate were measured using a discontinuous assay
containing the semicarbazide assay.21,22 Kinetic constants for
the dehydration of L-fuconate were determined using a coupled
enzyme assay as described by Yew and co-workers.23
Diﬀerential Scanning Fluorimetry. HsrTSβ and HsrTSγ
were assayed for shifts in melting temperature as previously
described.24 Each protein (5 μg) was assayed as puriﬁed and,
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also, in the presence of 5 mM MgCl2 or 5 mM MgCl2 and 5
mM D-erythronohydroxamate.
Methotrexate and 5-Fluorouracil Assays. Methotrexate
(Sigma-Aldrich) or 5-ﬂuorouracil (Sigma-Aldrich) (10 mM)
was incubated (800 μL) with 50 mM deuterated Tris−DCl, pD
7.9, 5 mM MgCl2 and 1 μM puriﬁed protein (rTSβ or rTSγ) in
D2O for 48 h at 37 °C. Immediately following incubation,
samples were analyzed for deuterium incorporation into
methotrexate or 5-ﬂuorouracil via 1H NMR. In the case of a
reaction that occurs without deuterium incorporation (with
methotrexate), the optical activity at 589 nm was measured for
an 800 μL reaction containing 10 mM methotrexate, 50 mM
HEPES, pH 7.9, 10 mM MgCl2, and 1 μM rTSβ in H2O.
Measurements were made at room temperature using a Jasco P-
1010 polarimeter (Jasco Inc.) conﬁgured with a halogen lamp
and 589 nm sodium d-line ﬁlter.
■ RESULTS AND DISCUSSION
Characterization of rTSγ. A sequence similarity network of
all proposed acid sugar dehydratases within the ENS is shown
in Supporting Information Figure S3. Clusters in the network
were assigned speciﬁc acid sugar dehydratase functions based
on homology to known acid sugar dehydratases, including
conservation of metal binding and catalytic residues. HsrTSγ,
together with the canonical FucD from Xanthomonas campestris
(XcFucD), is found within the fuconate dehydratase (FucD)
cluster at an e-value threshold of 10−80 (∼40% identity)
(Supporting Information Figure S3). HsrTSγ and XcFucD
separate as the e-value threshold is decreased to 10−180 (∼70%
identity) (Figure 1).23 The sequences of HsrTSγ and XcFucD
are 52% identical and 71% similar. In the mannonate
dehydratase subgroup of the ENS, proteins that are 67%
identical and 79% can catalyze diﬀerent enzymatic reactions.25
Therefore, experimental characterization is necessary to assign
an enzymatic function to HsrTSγ.
HsrTSγ was screened for dehydration activity with a library
of 72 acid sugars. Positive screening hits were veriﬁed via 1H
NMR, and steady-state kinetic constants were obtained for the
conﬁrmed substrates. The following sugars were positive hits in
the screen: L-fuconate, L-galactonate, D-arabinonate, L-
arabarate, and D-ribonate (Figure 2). All sugars with the
exception of L-arabarate were similarly identiﬁed as substrates
for XcFucD substrates.23 L-fuconate shows the greatest catalytic
eﬃciency (kcat/KM = 2.5 × 10
3 M−1 s−1), which is an order of
magnitude greater than that for the second best substrate, L-
galactonate (kcat/KM = 1.0 × 10
2 M−1 s−1) (Table 1). Together
with conservation of active site catalytic and metal binding
residues, the kinetic data establish rTSγ as an L-fuconate
dehydratase. In humans, as well as bacteria, L-fuconate
dehydratase is important for the metabolism of L-fucose,
which is found on the cellular surface of mammalian, insect, and
plant cells.23,26,27
The kcat/KM value for L-fuconate in HsrTSγ is 10-fold lower
than for XcFucD (4.5 × 104 M−1 s−1).23 This diﬀerence in
catalytic eﬃciency may not be surprising given the moderate
percent identity shared between the two enzymes. Additionally,
the 10-fold reduction could also be explained by post-
translational modiﬁcations in native HsrTSγ that may not be
present in the recombinant protein expressed in bacteria.
Crystal Structure of HsrTSγ. The crystal structure of
HsrTSγ with Mg2+ was solved by Hg-SAD phasing to a
resolution of 1.74 Å (Table 2, PDB 4A35). The structure
conﬁrms its membership within the MR subgroup of the ENS,
with XcFucD being the closest structural relative, as identiﬁed
by the DALI server23 (root-mean-square deviation of 1.03 Å for
430 Cα atoms, Z-score 62.0, PDB 2HXT) (Figure 3a). As a
member of the MR subgroup, HsrTSγ contains the following
canonical signature sequences in the core (β/α)7β-barrel
domain that are essential for catalysis (Supporting Information
Figure 1. Panel A, sequence similarity network for the L-fuconate
dehydratase subgroup at an e-value threshold of 10−80 (∼40%
identity). Panel B, network at an e-value threshold of 10−160 (∼65%
identity). Panel C, network at an e-value threshold of 10−180 (∼70%
identity). The nodes for XcFucD (PDB 2HXT) and rTSγ are colored
red and blue, respectively.
Figure 2. Structures of the top dehydration screening hits for rTSγ.
The ﬁrst order rate constants for dehydration are shown below the
corresponding acid sugar. Carbons with conserved stereochemistry to
L-fuconate have their hydroxyl groups highlighted in red.
Table 1. Steady-State Kinetic Parameters for rTSγ
substrate kcat (s
−1) KM (mM) kcat/KM (M
−1 s−1)
L-fuconate 0.5 ± 0.006 0.2 ± 0.01 2.5 × 103
L-galactonate 0.3 ± 0.01 3.0 ± 0.2 1.0 × 102
L-arabinarate 0.3 ± 0.004 4.0 ± 0.5 7.5 × 101
D-arabinonate 0.04 ± 0.002 2.0 ± 0.1 2.0 × 101
D-ribonate 0.002 ± 0.001 0.4 ± 0.2 5.0
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Figure S1): (1) a KxK motif (Lys 220-Val 221-Lys 222; HsrTSγ
residue numbering hereafter) at the end of the second β-strand
of the barrel domain for base-catalyzed proton abstraction, (2)
acidic residues Asp 250, Glu 276, and Glu 305 at the ends of
the third, fourth, and ﬁfth β-strands of the barrel domain,
respectively, which provide the ligands for the essential Mg2+
(Figure 3b), and (3) a His-Asp dyad (His 355-Asp 328) at the
ends of the seventh and sixth β-strands of the barrel domain,
respectively, which is the general acid catalyst for dehydration
of the enediolate intermediate.28 The RMSD of these
conserved residues between the HsrTSγ and XcFucD structures
is 0.31 Å, supporting their catalytic roles in HsrTSγ. Based on
the characterization of XcFucD, HsrTSγ is assumed to utilize
Lys 222 as the general basic catalyst for proton abstraction and
His 355 as the general acid catalyst for dehydration (Figure 3b).
Liang and co-workers previously postulated that HsrTSγ was
simply an isoform of HsrTSβ appended with a mitochondrial
signaling sequence at its N-terminus.9 Structural analysis of
HsrTSγ reveals that the extra 27 residues in the γ isoform
comprise the ﬁrst β-strand within the capping domain, a short α
helix, and a large portion of the “20s” loop. This β-strand is part
of a three-stranded β-sheet in the capping domain and packs
closely against the C-terminus, while the “20s” loop, a
conserved structural feature in MR subgroup members, is
known to confer substrate speciﬁcity while occluding solvent
from the active site29−32(Figure 4). Considering the structural
integrity of this region and its close proximity to the active site,
we propose that the extra 27 residues are not involved in
mitochondrial targeting, but instead are necessary for the
enzyme architecture and also possibly confer L-fuconate
dehydratase activity to HsrTSγ. This is supported by the lack
of deﬁnitive mitochondrial targeting signals identiﬁed from
various bioinformatics servers (data not shown).
Table 2. Data Collection and Reﬁnement Statistics for rTSγa
Data collection
space group P6522
no. of molecules 1
in asym. unit
cell dimensions
a (Å) 84.77
b (Å) 84.77
c (Å) 316.30
β° γ=120
resolution (Å) 1.74
no. of unique reﬂections 69165
Rmerge 0.04 (0.79)
completeness (%) 99.0 (93.9)
reﬁnement
resolution (Å) 20.00−1.74 (1.78−1.74)
Rcryst 0.152 (0.240)
Rfree 0.176 (0.288)
no. atoms
protein 3468
waters 594
bound ligands MG, EDO
ligand atoms 30
r.m.s deviations
bond lengths (Å) 0.015
bond angles (°) 1.11
PDB accession code 4A35
aBracketed values represent highest resolution shell.
Figure 3. Panel A, an overlay of the structure of rTSγ (PDB 4A35,
tan) and XcFucD bound to the substrate analog L-erythronohydrox-
amate (PDB 2HXT, blue). The Cα RMSD is 1.03 Å. Panel B shows an
overlay of the active site residues of the structures. The Cα RMSD for
these metal binding and catalytic residues is 0.31 Å. Residue number is
from the structure of rTSγ.
Figure 4. The structure of rTSγ (PDB 4A35) from side and top views.
Each structure has the ﬁrst 27 amino acids, which would be missing in
rTSβ, highlighted in red. The metal binding residues are highlighted in
green and catalytic residues in cyan.
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Pursuit of rTSβ Function. The importance of the N-
terminal 27 residues for HsrTSγ reactivity and integrity implies
that HsrTSβ, lacking this region, may have a deformed active
site (e.g., highly solvent exposed, Supporting Information
Figure S4) and be devoid of L-fuconate dehydratase activity.
Accordingly, we pursued enzymatic characterization of
recombinantly produced HsrTSβ. Our initial attempt to
subclone the gene encoding HsrTSβ, as described for HsrTSγ
(i.e., N-terminal His-tagged fusion protein), resulted in
insoluble protein. This suggests the importance of the N-
terminal 27 residues for protein stability, in addition to its role
in enzyme activity, and is also consistent with our observations
that truncation constructs of HsrTSγ lacking the N-terminal 5,
8, or 12 residues rendered the γ isoform to be highly insoluble
in E. coli (Supporting Information Figure S5). We managed to
subclone HsrTSβ as a tag-less construct which resulted in a low
level of expression in E. coli. The puriﬁed protein was screened
for dehydration activity on the library of 72 acid sugars as
described above. Based on the expectation that the complete
20s loop is necessary for catalysis, no dehydration activity was
detected for HsrTSβ. We also characterized HsrTSβ and
HsrTSγ by diﬀerential scanning ﬂuorimetry (Supporting
Information Table S1) and showed that HsrTSβ is more
thermolabile than HsrTSγ (ΔTm = 5 °C) and, unlike HsrTSγ, is
not thermally stabilized by the addition of D-erythronohydrox-
amate, an enediolate intermediate analog, thereby suggesting
that HsrTSβ does not bind the ligand. Taken together, our data
substantiate the hypothesis that the N-terminal 27 amino acid
residues in rTSγ are necessary for catalytic activity and confer
stability to the protein.
Several studies have observed uncharacteristically high levels
of HsrTSβ expression in tumor cell lines that also exhibit
resistance to either methotrexate or 5-ﬂuorouracil.2−7 This
correlation suggests the possibility that HsrTSβ, which does not
exhibit the L-fuconate dehydratase activity of HsrTSγ, could
instead harbor an alternative metabolic activity on these small
molecules in a manner that inactivates them. The observation
that HsrTSβ expression was found to be induced by TS
inhibitors indicates the protein may indeed be acting on these
drug molecules.2,4,33 To explore this possibility, methotrexate
and 5-ﬂuorouracil were analyzed for their ability to act as
substrates for HsrTSγ. Methotrexate has a proton alpha to the
carboxylate group of its glutamate side chain, which could be
racemized by an ENS member. Because methotrexate has more
than twice the molecular weight of L-fuconate, a truncation of
the “20s” loop, such as that seen in the β isoform, could expose
a larger binding surface to accommodate methotrexate in the
active site. Reactions were performed in D2O to determine if
exchange of the alpha proton (racemization) were occurring.
Also, 5-ﬂuorouracil was tested for deﬂuorination. No
incorporation of deuterium was observed via 1H NMR in the
presence of either HsrTSγ or HsrTSβ. Furthermore, to test a
racemization mechanism in which deuterium exchange does
not occur, methotrexate was incubated with HsrTSβ or HsrTSγ
in a polarimeter, but no change in optical rotation was
observed. These negative results, in conjunction with the lack of
identiﬁcation of an acid sugar substrate, allow us to conclude
that rTSβ is not involved in chemical modiﬁcation of
methotrexate or 5-ﬂuorouracil.
Dolnick proposed that HsrTSβ could function by transferring
a carboxylate group from S-adenosylmethionine to a lipophilic
acceptor.33−35 We ﬁnd this unlikely, considering that MR
subgroup members catalyze the abstraction of a proton alpha to
a carboxylate group, which is not a partial reaction known to
result in decarboxylation. Based on the in vitro function of
HsrTSγ and sequence homology to members of the MR
subgroup, HsrTSβ likely lacks an enzymatic activity. This,
however, does not prohibit HsrTSβ from participating in
protein−protein interactions that may produce the observed
resistance phenotype. In fact, TS can physically associate with
proteins of the same molecular weight as rTSα and rTSβ, and
conversely, rTSα and rTSβ could form a dimer (as observed in
the X-ray structure for rTSγ) and coimmunoprecipitate with
TS.4 Furthermore, preliminary data suggesting that rTS
proteins interact with dihydrofolate reductase (DHFR) could
explain the correlation between rTSβ overexpression and
methotrexate resistance.35 The characterization of HsrTSγ as an
L-fuconate dehydratase, coupled with the inability of HsrTSβ to
catalyze this reaction, points to a mechanism of resistance that
does not involve catalysis, but rather interactions with one of
the above proposed partners. Future in vitro studies are needed
to conﬁrm the rTS/TS or rTS/DHFR protein−protein
interactions and characterize their eﬀect on TS or DHFR
function.
■ CONCLUSION
Human rTSγ has been characterized in vitro as an L-fuconate
dehydratase that belongs to the mandelate racemase subgroup
of the enolase superfamily. The additional N-terminal amino
acids in rTSγ compared to rTSβ are important for catalysis and
stability, refuting previous proposals that rTSγ is merely a
variant of rTSβ with an N-terminal mitochondrial signaling
domain. rTSβ has been implicated in the resistance of tumor
cell lines to methotrexate and 5-ﬂuorouracil. Unfortunately,
rTSβ does not catalyze any chemical modiﬁcation of these
chemotherapeutics. Therefore, we believe attempts to sensitize
resistant cells lines via inhibitors to rTSβ will not be successful.
Based on the crystal structure of rTSγ and the enzymatic
screening performed in this study, we do not believe rTSβ is
catalytically active. Therefore, hypotheses that involve protein−
protein interactions are more likely the source of the observed
phenotypes and should be investigated further.
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